AI Brain Implant at KFSHRC Offers Parkinson's Relief with 50% Less Medication Riyadh hospital pioneers AI-powered therapy that delivers real-time brain stimulation for chronic neurological disorders
Riyadh
King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has successfully executed a groundbreaking procedure in the Middle East, implanting an advanced smart device within the brain to help manage chronic neurological disorders. This device monitors abnormal electrical activity and sends targeted electrical impulses to the affected regions, aiming to alleviate symptoms, decrease dependence on medication, and enhance patients' quality of life, independence, and health stability.
This state-of-the-art innovation enables patients to better control neurological symptoms and potentially lower medication doses by as much as 50%, reducing side effects and improving daily activities- especially for those with Parkinson's disease, epilepsy, and movement disorders.
The device's built-in artificial intelligence rapidly analyses brain signals to detect abnormal activity patterns and responds by providing targeted electrical stimulation to restore neural balance. This allows for highly accurate, adaptive treatment that adjusts to the patient's condition in real time without requiring continuous manual intervention from healthcare professionals.
While benefits start to appear within the first few weeks post-implantation, achieving optimal results requires a fine-tuning period of one to three months, during which electrical responses are calibrated according to real-time brain signals collected by the device.
The procedure utilises minimally invasive methods lasting only three to five hours, avoiding large surgical cuts. This approach lessens recovery time, minimises complications, and encourages a quicker return to everyday activities.
This achievement highlights KFSHRC's ongoing progress in harnessing artificial intelligence and medical innovation to provide high-precision, specialised care, meet patient needs, and shape an advanced therapeutic model for the region and beyond.
It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
3 days ago
- Mid East Info
Filipino Healthcare Worker Recovers After Removal of Brain Tumor, Nearly the Size of a Tennis Ball, at Aster Hospital Mankhool
A 41-year-old Filipino woman, Ms. Jovelyn Sison Omes, a healthcare assistant at an aesthetic clinic in Dubai, underwent life-saving brain surgery at Aster Hospital, Mankhool, ranked No. 4 on Newsweek's World's Best Hospitals in the UAE list for 2025. Ms. Omes had been experiencing severe headaches, nausea, double vision, and a full-body seizure – alarming symptoms that prompted immediate medical evaluation. Upon her admission on November 27, 2024, scans revealed a large, non-cancerous brain tumor on the right side of her brain, known as a falcine meningioma. The tumor had grown across the center of her brain to the opposite side, causing swelling and pressure on critical brain areas, leading to a condition called cerebral edema and mass effect. Dr. Prakash Nair, Consultant Neurosurgeon at Aster Hospital, Mankhool, compared the tumor's size to that of a tennis ball. Despite a medical history of asthma and high cholesterol, Ms. Omes was not on any regular medications. Her symptoms included persistent headaches (VAS 8/10), a seizure with tongue bite, temporary confusion, and a brief episode of double vision. She did not report limb weakness or trauma. On November 28, 2024, Dr. Prakash Nair and his team performed a complex brain surgery on Ms. Jovelyn Sison Omes at Aster Hospital, Mankhool, to remove the tumor located near a critical brain region responsible for limb movement. The patient was placed under general anesthesia, and the surgical team accessed the tumor through four small openings in the skull. Using advanced tools including a state-of-the-art microscope and ultrasonic aspirator (CUSA), the team performed a Simpson Grade 1 resection, meaning the tumor and its roots were entirely removed — significantly lowering the risk of recurrence. Bleeding was controlled without the need for transfusion, and the skull was reconstructed with precision. Following surgery, Ms. Omes was transferred to the ICU and weaned off ventilator support within 24 hours. A follow-up scan confirmed complete tumor removal with no complications. She was mobilized the next day, resumed eating normally within hours, and responded well to physiotherapy. Discharged on December 5, 2024, she made a full recovery with no neurological issues. 'This case highlights the importance of timely diagnosis and advanced neurosurgical care. The tumor was located in a challenging area near vital brain structures, but we were able to remove it completely without causing any damage,' said Dr. Prakash Nair, Consultant Neurosurgeon at Aster Hospital, Mankhool, who led the surgery. He added, 'In cases of Simpson Grade 1 resection, the recurrence rate after 10 years is less than 9%2, which is extremely promising for the patient's long-term prognosis.' Falcine meningiomas make up about 9% of all intracranial meningiomas1 and are more common in women, with a two- to three-fold higher occurrence than in men3. These tumors are typically diagnosed more often with increasing age. In this case, the tumor's fibroblastic subtype added to the complexity of the condition. Ms. Jovelyn Sison Omes expressed her deep gratitude to Dr. Nair and the medical team, saying, 'I'm incredibly thankful to Dr. Nair and the entire team for saving my life. I had been suffering from debilitating symptoms, but today, I'm pain-free, seizure-free, and back to work. As a healthcare worker, I urge everyone not to ignore warning signs. Early intervention truly saved my life, and I hope my story encourages others to seek help when something doesn't feel right. With follow-up imaging confirming a successful outcome and no neurological deficits, Ms. Omes is expected to lead a full and healthy life. Her case stands as a testament to the power of timely diagnosis, surgical expertise, and compassionate care — all hallmarks of Aster Hospital Mankhool's commitment to clinical excellence.
Mid East Info
14-06-2025
- Mid East Info
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies - Middle East Business News and Information
King Faisal Specialist Hospital & Research Centre KFSHRC continues to redefine global healthcare through its Smart Hospital initiative, leveraging AI, simulation, and immersive technologies across its departments. These technologies have supported KFSHRC to enhance workforce training, clinical care, and operational efficiency. The Academic & Training Affairs (ATA) division is leading this transformation, deploying next-generation tools such as simulation labs, e-learning, and virtual reality (VR) to deliver hands-on, immersive training. These technologies allow healthcare professionals to rehearse complex procedures from emergency care to surgical planning, strengthening clinical preparedness and patient safety. The Patient Flow & Capacity Command Centre enhances operational efficiency by applying AI to forecast demand, manage resources, and monitor patient flow in real time. Since its launch, the Centre has completed over 170,000 interventions, cutting bed wait times from 32 to 6 hours and reducing emergency delays by 14%. In 2024 alone, the hospital received over 46,000 new patients and processed more than 79,000 referrals. Smart tools, such as the Noor robot, enhance the patient experience by providing real-time assistance and improving access to services. Across departments such as Radiology, Pathology, Genomics, and Oncology, AI enhances diagnosis, interpretation, early interventions and personalized care for complex diseases. Driving these innovations is KFSHRC's Centre for Healthcare Intelligence (CHI), which has developed over 20 AI applications in medical imaging, clinical decision support, and operations. In partnership with the Saudi Commission for Health Specialties, CHI also leads national AI training programs to build future-ready digital health talent. At the 2024 GAIN Summit CHI unveiled a generative AI platform to synthesize patient data, accelerate diagnostics, and streamline triage. KFSHRC ranks among Saudi Arabia's top 20 government entities in the 2025 Technology Adoption Readiness Index and received the 2024 Zimam Best AI Program Award, recognizing its leadership in AI, robotic surgery, and digital innovation. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings.
Mid East Info
13-06-2025
- Mid East Info
First of Its Kind in the Region
KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Patient In a medical achievement considered the first of its kind in the region, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has successfully performed an endoscopic sleeve gastroplasty (ESG) on a patient who had previously undergone a kidney transplant, a case that requires meticulous management of immunosuppressive medications and the prevention of any complications that could jeopardize the transplanted organ. This procedure marks a significant advancement in providing safe treatment solutions for transplant recipients, to improve their graft survival and quality of life. Known as Endoscopic Sleeve Gastroplasty (ESG), the procedure differs from surgical sleeve gastrectomy in that it requires no abdominal incisions, which is important for transplant patients. Instead, it uses an endoscope inserted through the mouth to suture the stomach internally, effectively reducing its volume and enabling the patient to lose weight and improve overall health. The procedure aimed to address obesity and metabolic, which are among the leading factors that can negatively impact the health of a transplanted kidney, increase cardiovascular risk, and reduce long-term patient outcomes. The procedure was performed by a multidisciplinary team of medical experts, led by Dr. Ehab Abufarhaneh, Consultant in Adult Transplant Gastroenterology and Hepatology. The team included gastroenterologists, an upper GI surgeon, transplant surgeons, transplant Nephrology, and transplant anaesthesiologists, all supported by highly trained nursing staff to ensure the highest level of safety, with particular focus on managing the patient's immunosuppressive regimen—critical to preserving kidney graft function. This achievement underscores the pivotal role of KFSHRC's Organ Transplant Centre of Excellence as a leading medical environment capable of delivering precise interventions for complex transplant cases. By adopting innovative techniques tailored to the unique needs of transplant patients and developing treatment protocols that address post-transplant challenges, the centre reinforces its position as a regional referral hub for cases beyond the scope of conventional treatment pathways. The success of this procedure further exemplifies KFSHRC's ongoing commitment to delivering advanced, patient-centred healthcare and fulfilling its vision of being the optimal choice for patients supported by an integrated ecosystem of education, research, and clinical excellence that aligns with the ambitions of Saudi Arabia's health sector. It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
